In silico prediction of caco-2 cell permeability by a classification QSAR approach

Molecular Informatics

Volumn 30, Issue 4, 2011, Pages 376-385

  The, Hai Pham ^a   González Álvarez, Isabel ^b   Bermejo, Marival ^b   Sanjuan, Victor Mangas ^b   Centelles, Inmaculada ^c   Garrigues, Teresa M ^c   Cabrera Pérez, Miguel Ángel ^a  

^a CENTRAL UNIVERSITY OF LAS VILLAS   (Cuba)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Caco 2; Classification model; In vitro permeability assay; Intestinal permeability; Quantitative structure activity relationship

Indexed keywords

CLASSIFICATION (OF INFORMATION); COMPUTATIONAL CHEMISTRY; DIGITAL LIBRARIES; MOLECULAR GRAPHICS; VIRTUAL REALITY;

CACO-2; CACO-2 PERMEABILITY; CLASSIFICATION MODELS; HUMAN INTESTINAL ABSORPTIONS; IN VITRO PERMEABILITY ASSAY; IN-SILICO; IN-VITRO; INTESTINAL PERMEABILITIES; QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP; VIRTUAL SCREENING;

ASSAYS;

ACCURACY; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; DATA BASE; HUMAN; IN VITRO STUDY; INTESTINE ABSORPTION; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 79958792928     PISSN: 18681743     EISSN: 18681751     Source Type: Journal    
DOI: 10.1002/minf.201000118     Document Type: Article

References (62)

1. R. A. Prentis, Y. Lis, S. R. Walker, Br. J. Clin. Pharmacol. 1988, 25, 387.
2. T. Kennedy, Drug Discov. Today 1997, 2, 436.
3. G. W. Caldwell, Z. Yan, W. Tang, M. Dasgupta, B. Hasting, Curr. Top Med. Chem. 2009, 9, 965.
4. A. L. Ungell, Drug Discov. Today Technol. 2004, 1, 423.
5. A. Avdeef, S. Bendels, L. Di, B. Faller, M. Kansy, K. Sugano, Y. Yamauchi, J. Pharm. Sci. 2007, 96, 2893.
6. P. Artursson, K. Palm, K. Luthman, Adv. Drug Deliv. Rev. 2001, 46, 27.
7. J. D. Irvine, L. Takahashi, K. Lockhart, J. Cheong, J. W. Tolan, H. E. Selick, J. R. Grove, J. Pharm. Sci. 1999, 88, 28.
8. S. Tavelin, J. Taipalensuu, F. Hallbook, K. S. Vellonen, V. Moore, P. Artursson, Pharm. Res. 2003, 20, 373.
9. H. Bohets, P. Annaert, G. Mannens, L. Van Beijsterveldt, K. Anciaux, P. Verboven, W. Meuldermans, K. Lavrijsen, Curr. Top Med. Chem. 2001, 1, 367.
10. M. S. Ku, AAPS J. 2008, 10, 208.
11. D. S. Wishart, Drugs R. D. 2007, 8, 349.
12. C. A. Bergstrom, Expert. Opin. Drug Metab. Toxicol. 2005, 1, 613.
13. K. Palm, K. Luthman, A. L. Ungell, G. Strandlund, P. Artursson, J. Pharm. Sci. 1996, 85, 32.
14. H. van de Waterbeemd, G. Camenisch, G. Folkers, O. A. Raevsky, Quan. Struct. Activ. Relat. 1996, 15, 480.
15. F. Yamashita, S. Fujiwara, M. Hashida, J. Chem. Inf. Comput. Sci. 2002, 42, 408.
16. I. Hubatsch, E. G. Ragnarsson, P. Artursson, Nat. Protoc. 2007, 2, 2111.
17. A. Dahan, J. M. Miller, J. M. Hilfinger, S. Yamashita, L. X. Yu, H. Lennernas, G. L. Amidon, Mol. Pharm. 2010, 7, 1388.
18. Y. Marrero-Ponce, M. A. Cabrera, V. Romero, M. Bermejo, D. Siverio, F. Torrens, Internet. Electron. J. Mol. Des. 2005, 4, 124.
19. STATISTICA (data analysis software system), Version 8, StatSoft, Inc., www.statsoft.com, 2007.
20. M. V. Varma, S. Khandavilli, Y. Ashokraj, A. Jain, A. Dhanikula, A. Sood, N. S. Thomas, O. Pillai, P. Sharma, R. Gandhi, S. Agrawal, V. Nair, R. Panchagnula, Curr. Drug Metab. 2004, 5, 375.
21. M. Kansy, H. Fischer, K. Kratzat, F. Senner, B. Wagner, I. Parrilla, in Pharmacokinetic Optimization in Drug Research: Biological, Physicochemical, and Computational Strategies (Eds: B. Testa, H. van de Waterbeemd, G. Folkers, R. H. Guy), Verlag Helvetica Chimica Acta, Zürich, Switzerland, 2001, pp. 447.
22. R. Todeschini, V. Consonni, A. Mauri, M. Pavan, DRAGON, 5.4 ed., Talete srl, Milano, 2006.
23. D. Weininger, J. Chem. Inf. Comput. Sci. 1988, 28, 31.
24. M. J. S. Dewar, E. G. Zoebisch, E. F. Healy, J. J. P. Stewart, J. Am. Chem. Soc. 1985, 107, 3902.
25. J. Frank, MOPAC 6.0 ed., Seiler Research Laboratory. U.S. Air Force Academy, 1993.
26. J. A. Cooper, R. Saracci, P. Cole, Brit. J. Cancer 1979, 39, 87.
27. C. E. Metz, Sem. Nuc. Med. 1978, 8, 283.
28. A. Golbraikh, A. Tropsha, J. Mol. Graph. Model. 2002, 20, 269.
29. L. Eriksson, J. Jaworska, A. P. Worth, M. T. Cronin, R. M. McDowell, P. Gramatica, Environ. Health Perspect. 2003, 111, 1361.
30. a) L. Saiz-Urra, M. P. Gonzalez, Y. Fall, G. Gomez, Eur. J. Med. Chem. 2007, 42, 64
31. b) L. Saiz-Urra, M. P. Gonzalez, I. G. Collado, R. Hernandez-Galan, J. Mol. Graph. Model. 2007, 25, 680.
32. a) M. Hu, J. Chen, D. Tran, Y. Zhu, G. Leonardo, J. Drug Target 1994, 2, 79
33. b) M. Hu, J. Chen, Y. Zhu, A. H. Dantzig, R. E. J. Stratford, M. T. Kuhfeld, Pharm. Res. 1994, 11, 1405.
34. R. Todeschini, V. Consonni, Handbook of Molecular Descriptors, Wiley VCH, Weinheim, Germany, 2000.
35. U. Norinder, T. Osterberg, P. Artursson, Pharm. Res. 1997, 14, 1786.
36. U. Norinder, T. Osterberg, J. Pharm. Sci. 2001, 90, 1076.
37. L. B. Kier, L. H. Hall, J. W. Frazer, J. Math. Chem. 1991, 7, 229.
38. L. B. Kier, L. H. Hall, J. Chem. Inf. Comput. Sci. 1997, 37, 548.
39. S. Agatonovic-Kustrin, R. Beresford, A. P. Yusof, J. Pharm. Biomed. Anal. 2001, 25, 227.
40. F. R. Burden, J. Chem. Inf. Comput. Sci. 1989, 29, 225.
41. R. Todeschini, P. Gramatica, Perspect Drug Discov. Des. 1998, 9/10/11, 355.
42. V. Consonni, R. Todeschini, M. Pavan, J. Chem. Inf. Comput. Sci. 2002, 42, 682.
43. D. F. Veber, S. R. Johnson, H. Y. Cheng, B. R. Smith, K. W. Ward, K. D. Kopple, J. Med. Chem. 2002, 45, 2615.
44. a) T. J. Hou, X. J. Xu, J. Chem. Inf. Comput. Sci. 2003, 43, 2137
45. b) T. Hou, J. Wang, W. Zhang, X. Xu, J. Chem. Inf. Model. 2007, 47, 208.
46. H. van de Waterbeemd, G. Camenisch, G. Folkers, J. R. Chretien, O. A. Raevsky, J. Drug Target 1998, 6, 151.
47. S. Winiwarter, F. Ax, H. Lennernas, A. Hallberg, C. Pettersson, A. Karlen, J. Mol. Graph. Model. 2003, 21, 273.
48. J. Kelder, P. D. Grootenhuis, D. M. Bayada, L. P. Delbressine, J. P. Ploemen, Pharm. Res. 1999, 16, 1514.
49. M. V. Varma, R. S. Obach, C. Rotter, H. R. Miller, G. Chang, S. J. Steyn, A. El-Kattan, M. D. Troutman, J. Med. Chem. 2010, 53, 1098.
50. A. K. Ghose, V. N. Viswanadhan, J. J. Wendoloski, J. Comb. Chem. 1999, 1, 55.
51. J. Guo, Q. Ping, G. Jiang, J. Dong, S. Qi, L. Feng, Z. Li, C. Li, Int. J. Pharm. 2004, 278, 415.
52. U. K. Walle, T. Walle, Drug Metab. Dispos. 1998, 26, 343.
53. J. Jaworska, N. Nikolova-Jeliazkova, T. Aldenberg, Altern. Lab. Anim. 2005, 33, 445.
54. V. E. Thiel-Demby, J. E. Humphreys, L. A. St John Williams, H. M. Ellens, N. Shah, A. D. Ayrton, J. W. Polli, Mol. Pharm. 2009, 6, 11.
55. J. M. Geuns, P. Augustijns, R. Mols, J. G. Buyse, B. Driessen, Food Chem. Toxicol. 2003, 41, 1599.
56. N. M. Griffiths, B. H. Hirst, N. L. Simmons, J. Pharmacol. Exp. Ther. 1994, 269, 496.
57. D. A. Laska, J. O. Houchins, S. E. Pratt, J. Horn, X. Xia, B. R. Hanssen, D. C. Williams, A. H. Dantzig, T. Lindstrom, In Vitro Cell Dev. Biol. Anim. 2002, 38, 401.
58. P. Artursson, J. Karlsson, Biochem. Biophys. Res. Commun. 1991, 175, 880.
59. M. Rowland, T. N. Tozer, Clinical Pharmacokinetics: Concepts and Applications, 3rd ed., Lea & Febiger, Philadephia, 1995, p. 601.
60. Y. Marrero-Ponce, M. A. Cabrera Perez, V. Romero Zaldivar, H. Gonzalez Diaz, F. Torrens, J. Pharm. Pharm. Sci. 2004, 7, 186.
61. J. A. Castillo-Garit, Y. Marrero-Ponce, F. Torrens, R. Garcia-Domenech, J. Pharm. Sci. 2008, 97, 1946.
62. H. H. Refsgaard, B. F. Jensen, P. B. Brockhoff, S. B. Padkjaer, M. Guldbrandt, M. S. Christensen, J. Med. Chem. 2005, 48, 805.